CNVIF (Conavi Medical) Ending Cash Position: $3.28 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CNVIF Conavi Medical Corp CNVIF
4 GF Score
Price $0.14
! 5 Warning Signs
View Full Analysis

What is Conavi Medical Ending Cash Position?

Conavi Medical CNVIF -1.47% 4 Ending Cash Position is $3.28 Mil as of Mar. 2026. GuruFocus rates CNVIF with a GF Score™ of 4/100. The stock has 5 warning signs investors should review.

Conavi Medical's Ending Cash Position for the quarter that ended in Mar. 2026 was $3.28 Mil.

Conavi Medical's quarterly Ending Cash Position declined from Sep. 2025 ($4.22 Mil) to Dec. 2025 ($0.70 Mil) but then increased from Dec. 2025 ($0.70 Mil) to Mar. 2026 ($3.28 Mil).

Conavi Medical's annual Ending Cash Position increased from . 20 ($0.00 Mil) to Sep. 2024 ($0.32 Mil) and increased from Sep. 2024 ($0.32 Mil) to Sep. 2025 ($4.22 Mil).

Conavi Medical Ending Cash Position Related Terms

Conavi Medical Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Conavi Medical's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Conavi Medical Ending Cash Position Chart

Conavi Medical Annual Data
Trend Sep24 Sep25
Ending Cash Position
0.32 4.22

Conavi Medical Quarterly Data
Sep23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only 0.72 8.26 4.22 0.70 3.28
CNVIF
4GF Score
Conavi Medical Corp CNVIF
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Conavi Medical Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Conavi Medical's Ending Cash Position for the fiscal year that ended in Sep. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0.315+3.907
=4.22

Conavi Medical's Ending Cash Position for the quarter that ended in Mar. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0.708+2.567
=3.28

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $3.28 Mil mean?
Conavi Medical (CNVIF) has a Ending Cash Position of $3.28 Mil as of Mar. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Conavi Medical and its competitors.
Is Conavi Medical's Ending Cash Position too high?
Conavi Medical's current Ending Cash Position is $3.28 Mil. Overall, Conavi Medical has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Conavi Medical's Ending Cash Position compare to ABT and SYK?
Conavi Medical's Ending Cash Position of $3.28 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Medical Devices & Instruments company?
A good Ending Cash Position depends on the Medical Devices & Instruments industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Conavi Medical and its competitors. Conavi Medical's current Ending Cash Position is $3.28 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Conavi Medical stock overvalued right now?
Conavi Medical (CNVIF) has a current Ending Cash Position of $3.28 Mil. The current Ending Cash Position is $3.28 Mil. Conavi Medical's overall GF Score™ is 4/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Conavi Medical (CNVIF), the current Ending Cash Position is $3.28 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Conavi Medical Business Description

Other Exchanges CNVI:Canada
Address 293 Lesmill Road, Toronto, ON, CAN, M3B 2V1
Conavi Medical Corp is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. Its Novasight Hybrid System is the first system to combine both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries.
4GF Score

Get the complete analysis for CNVIF

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.14
Price